Latest Advances

  • Condition: Hodgkin's Lymphoma during Pregnancy
  • Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Treatment Used: Cannabis
  • Number of Patients: 1
  • Published —
The study research the use of cannabis in treating a pregnant patient with Hodgkin's lymphoma.
  • Condition: Hodgkin Lymphoma
  • Journal: The Lancet. Oncology
  • Treatment Used: Omission of Radtiotherapy
  • Number of Patients: 1100
  • Published —
This study evaluated whether radiotherapy (cancer treatment that uses beams of intense energy to kill cancer cells) can be omitted without loss of effectiveness in early-stage unfavorable Hodgkin lymphoma (a cancer of the lymphatic system).
  • Condition: Hodgkin Lymphoma (HL)
  • Journal: PloS one
  • Treatment Used: Combination Chemotherapy
  • Number of Patients: NULL
  • Published —
This study evaluated the incidence of chromosomal aberrations (abnormalities) in sperm of patients receiving combination chemotherapy for Hodgkin lymphoma (a cancer of the lymphatic system, which is part of the immune system).
  • Condition: Relapsed/refractory Aggressive Lymphoma
  • Journal: Medicine
  • Treatment Used: Gemcitabine, Cisplatin, and Dexamethasone Versus Ifosfamide, Carboplatin, and Etoposide
  • Number of Patients: 110
  • Published —
In this study, researchers compared the outcomes of gemcitabine, cisplatin, and dexamethasone versus ifosfamide, carboplatin, and etoposide for relapsed/refractory aggressive lymphoma.
  • Condition: Fertility Preservation Options for Female Patients With Hodgkin Lymphoma (HL)
  • Journal: Obstetrical & gynecological survey
  • Treatment Used: Upfront Fertility Preservation
  • Number of Patients: 0
  • Published —
This article discusses fertility preservation options in female patients who will be undergoing chemotherapeutic agents in the treatment of Hodgkin lymphoma (HL).
  • Condition: Chemosensitive Patients with Hodgkin Lymphoma (HL)
  • Journal: BMC cancer
  • Treatment Used: Haploidentical Related Donor vs. HLA-Identical Donor Transplantation
  • Number of Patients: 198
  • Published —
This study compared haploidentical related donor versus HLA-identical donor transplantation for chemosensitive patients with Hodgkin lymphoma (HL).
  • Condition: Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)
  • Journal: BMC cancer
  • Treatment Used: Autologous Stem Cell Transplantation (ASCT)
  • Number of Patients: 0
  • Published —
This article provided a a European perspective on the available treatment options for patients with relapsed/refractory (R/R) Hodgkin lymphoma undergoing autologous stem cell transplantation (ASCT).
  • Condition: Hodgkin Transformation
  • Journal: Haematologica
  • Treatment Used: ABVD-based Regimens
  • Number of Patients: 94
  • Published —
The study researched the outcomes of patients with Hodgkin transformation.
  • Condition: Hodgkin's Lymphoma
  • Journal: The Lancet. Haematology
  • Treatment Used: Brentuximab Vedotin plus Nivolumab
  • Number of Patients: 46
  • Published —
This study tested the safety and efficacy of using brentuximab vedotin plus nivolumab to treat patients with Hodgkin's lymphoma.
  • Condition: Hodgkin Lymphoma
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: ABVD Therapy
  • Number of Patients: 85
  • Published —
This study evaluated the effectiveness and outcomes of patients with limited-stage Hodgkin lymphoma (type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes) treated with ABVD therapy (a chemotherapy regimen) and determined whether omitting radiotherapy (cancer treatment that uses beams of intense energy to kill cancer cells) enabled the achievement of complete response (CR) after chemotherapy.
  • Condition: Lymphoma During Pregnancy
  • Journal: Current oncology reports
  • Treatment Used: Therapeutic Approaches
  • Number of Patients: 0
  • Published —
The study researched the treatment of lymphoma during pregnancy.
  • Condition: Relapsed or Refractory Classical Hodgkin Lymphoma
  • Journal: Japanese journal of clinical oncology
  • Treatment Used: Nivolumab
  • Number of Patients: 17
  • Published —
The study researched the outcomes of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.
Showing 1-12 of 118